Volume 10, Number 4—April 2004
Research
Human Metapneumovirus Infection among Children Hospitalized with Acute Respiratory Illness
James A. Mullins*, Dean D. Erdman*, Geoffrey A. Weinberg†, Kathryn M. Edwards‡, Caroline B. Hall†, Frances J. Walker*, Marika Iwane*, and Larry J. Anderson*
Table 2
Clinical characteristics of HMPV-positive patients compared with RSV-positive patients and the rest of the study cohort, New Vaccine Surveillance Network acute respiratory illness study, August 2000–September 2001
| HMPV-positive, n = 26 | RSV-positive, n = 125 | Rest of cohort, n = 517 | |
|---|---|---|---|
| Characteristic |
n (%) |
n (%) |
n (%) |
| Presenting Symptoms |
|||
| Cough |
24 (92)a,b |
124 (99) |
333 (64) |
| Fever |
19 (73) |
85 (68) |
383 (74) |
| Nasal Congestion |
20 (77) |
110 (88) |
329 (64) |
| Shortness of Breath |
21 (81) |
119 (95) |
334 (65) |
| Hospital Course |
|||
| Admitted to ICU |
4 (15) |
6 ( 5) |
28 ( 5) |
| Received supplemental O2 |
14 (54)a,c |
76(61) |
51 (29) |
| Intubated |
2 ( 8) |
3 (2) |
10 (2) |
| Chest x-ray findings |
(n = 23) |
(n = 105) |
(n = 304) |
| Chest x-ray performed |
23 (88)a,c |
105 (84) |
304 (59) |
| Any pneumonia/infiltration |
9 (39) |
25 (23) |
77 (25) |
| Hyperinflation | 11 (48) | 54 (51) | 103 (34) |
aComparison of HMPV-positive patients to rest of cohort.
bp<0.001.
cp<0.01
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.